BACKGROUND AND OBJECTIVE: Distinction between B-cell chronic leukemias can be
difficult due to overlap in cell morphology and immunologic features. We investigated, by …

By multiparameter flow cytometry, the T‐cell‐associated markers CD4 and CD7 were
aberrantly coexpressed on a case of B‐cell chronic lymphocytic leukemia (CLL). The CLL …

Purpose: Despite advances in the treatment of chronic lymphocytic leukemia (CLL), the
disease remains incurable with standard therapies and relapse is inevitable. A growing …

Background Chronic lymphocytic leukemia (CLL) is one of the commonest leukemias that
has been reported extensively throughout the literature. The characteristic phenotype …

Abstract Abstract 2478 Introduction: Flow cytometric immunophenotyping is critical for
accurate diagnosis of CD5-positive chronic lymphocytic leukemia (CLL). CLL is classically …

OBJECTIVE: The aim of this study was to assess the prognostic value of CD49d expression
in Turkish chronic lymphocytic leukemia patients. METHODS: Data for 118 patients from a …

Chronic lymphocytic leukemia (CLL) is recognized as a unique lymphoproliferative disorder
of CD5+ B cells. However, many published series of CLL included a subgroup of CD5 …

B-Chronic lymphocytic leukaemia (B-CLL) is a monoclonal malignancy characterized by an
accumulation of terminally differentiated small and anergic B lymphocytes in the blood, bone …

Background Flow cytometry immunophenotyping (FCIP) is used for rapid, specific diagnosis
of B-chronic lymphoproliferative disorders (BCLPDs). However, cases may deviate from the …

B cells in chronic lymphocytic leukaemia (CLL) usually express the CD5 antigen, which
appears to participate in the pathogenesis of autoimmune phenomena. However, 7–20% of …